Skip to content

Daunorubicin / Cytarabine

Published: July 26, 2026Updated: August 26, 2026

Vyxeos is a liposomal combination chemotherapy containing daunorubicin and cytarabine, designed for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults, specifically targeting therapy-related AML or AML with myelodysplasia-related changes. This medication works by delivering two chemotherapy agents that work together to inhibit cancer cell growth and promote cancer cell death.

Quick summary

Vyxeos is a combination chemotherapy for adults with certain types of newly-diagnosed acute myeloid leukemia.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

RxNorm
1942744
Generic
Vyxeos
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Vyxeos is indicated for the treatment of newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) in adult patients.

Vyxeos combines two chemotherapy agents—daunorubicin (an anthracycline that intercalates into DNA) and cytarabine (a nucleoside analog that inhibits DNA synthesis)—delivered in a liposomal formulation that allows for optimized pharmacokinetics and targeted delivery to cancer cells.

Vyxeos carries risks of severe side effects including cardiotoxicity, myelosuppression, and prolonged cytopenias. It is administered by intravenous infusion. Cardiac monitoring and regular blood tests are required during treatment. This is a specialty medication that requires supervision by an oncologist or hematologist.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy